About Us

MS Pharma is a multinational pharmaceutical company headquartered in Amman – Jordan that manufactures and markets innovative products across Middle East, Africa and Europe. The company leverages 9 manufacturing sites in Algeria, Jordan, Turkey, KSA and Greece to sell its products in over 60 countries worldwide, with a capacity of 600 million boxes per year. We have the ability to manufacture different dosage forms from solid (including soft gelatin capsule), liquid, semi-solids, oral oncology, multipurpose injectables, and oncology injectables. MS Pharma has a diversified team of 2,700 ambitious and highly skilled employees, which helped to achieve more than 2,000 registered products and 365 products in the pipeline. We cover a wide range of therapeutic classes in the chronic and acute diseases from Cardiovascular and Diabetes, Central Nervous System, Oncology, Autoimmune Diseases, Hematology, Musculoskeletal, Respiratory, Alimentary, Systemic Antibiotics to Dermatology, beside a wide range of cosmeceutical and consumer products. Recently MS Pharma acquired Genepharm – a multinational pharmaceutical company that is based in Greece and focuses on chronic diseases like Cardiovascular, CNS and Oncology.

Where we are coming from...

2011
Q3 2011
Q3 2013
Q3 2016
2018
2019
2024
1989
2009

2011

Integration of UPM & EL KENDI

2011

Q3 2011

Acquisition of injectables plant in Jordan

Q3 2011

Q3 2013

Launch of the Corporate Head Office in Jordan

Q3 2013

Q3 2016

Acquisition of generics manufacturing plant in Turkey

Q3 2016

2018

2018

2019

2019

2024

– Expansion into:
New Countries & New Therapeutic areas
– Expansion Via:
Start-ups, Alliances & M&A activities

1989

Creation in Jordan

1989

2009

EL KENDI Manufacturing start-up in Algeria

2009